Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 0 | $0 |
Sells | 16 | $883,550 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
30 May 2024 17:54 | ELVN | Enliven Therapeutics Inc | HOHL BENJAMIN | CHIEF FINANCIAL OFFICER | 28 May 2024 | Sale | 10 | 24.34 | 243 | D |
30 May 2024 17:54 | ELVN | Enliven Therapeutics Inc | HOHL BENJAMIN | CHIEF FINANCIAL OFFICER | 28 May 2024 | Sale | 2,334 | 23.4184 | 54,659 | D |
30 May 2024 17:54 | ELVN | Enliven Therapeutics Inc | HOHL BENJAMIN | CHIEF FINANCIAL OFFICER | 28 May 2024 | Sale | 1,906 | 22.89 | 43,628 | D |
07 May 2024 18:58 | ELVN | Enliven Therapeutics Inc | HOHL BENJAMIN | CHIEF FINANCIAL OFFICER | 03 May 2024 | Sale | 1,000 | 22.5 | 22,500 | D |
01 May 2024 19:02 | ELVN | Enliven Therapeutics Inc | HOHL BENJAMIN | CHIEF FINANCIAL OFFICER | 29 Apr 2024 | Sale | 3,250 | 16.9737 | 55,165 | D |
15 Apr 2024 19:04 | ELVN | Enliven Therapeutics Inc | HOHL BENJAMIN | CHIEF FINANCIAL OFFICER | 11 Apr 2024 | Sale | 10,223 | 25.0386 | 255,970 | D |
15 Apr 2024 19:04 | ELVN | Enliven Therapeutics Inc | HOHL BENJAMIN | CHIEF FINANCIAL OFFICER | 11 Apr 2024 | Sale | 3,777 | 23.8759 | 90,179 | D |
29 Mar 2024 17:59 | ELVN | Enliven Therapeutics Inc | HOHL BENJAMIN | CHIEF FINANCIAL OFFICER | 27 Mar 2024 | Sale | 182 | 18.7186 | 3,407 | D |
29 Mar 2024 17:59 | ELVN | Enliven Therapeutics Inc | HOHL BENJAMIN | CHIEF FINANCIAL OFFICER | 27 Mar 2024 | Sale | 3,068 | 18.2189 | 55,896 | D |
29 Feb 2024 17:27 | ELVN | Enliven Therapeutics Inc | HOHL BENJAMIN | CHIEF FINANCIAL OFFICER | 27 Feb 2024 | Sale | 3,250 | 16.9732 | 55,163 | D |
31 Jan 2024 21:20 | ELVN | Enliven Therapeutics Inc | HOHL BENJAMIN | CHIEF FINANCIAL OFFICER | 29 Jan 2024 | Sale | 3,250 | 15.8118 | 51,388 | D |
02 Jan 2024 19:59 | ELVN | Enliven Therapeutics Inc | HOHL BENJAMIN | Chief Financial Officer | 02 Jan 2024 | Sale | 9,383 | 15.01 | 140,839 | D |
02 Jan 2024 19:59 | ELVN | Enliven Therapeutics Inc | HOHL BENJAMIN | Chief Financial Officer | 29 Dec 2023 | Sale | 20 | 15 | 300 | D |
02 Jan 2024 19:59 | ELVN | Enliven Therapeutics Inc | HOHL BENJAMIN | Chief Financial Officer | 28 Dec 2023 | Sale | 2,467 | 15.0742 | 37,188 | D |
27 Dec 2023 17:26 | ELVN | Enliven Therapeutics Inc | HOHL BENJAMIN | Chief Financial Officer | 22 Dec 2023 | Sale | 1,030 | 15.0728 | 15,525 | D |
27 Dec 2023 17:26 | ELVN | Enliven Therapeutics Inc | HOHL BENJAMIN | Chief Financial Officer | 26 Dec 2023 | Sale | 100 | 15 | 1,500 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)